World Parkinson’s Day: A Time to Raise Awareness and Strengthen Support

Apr 11, 2025 | Non classé

April 11 marks World Parkinson’s Day – an opportunity to raise global awareness about Parkinson disease (PD) and acknowledge the experiences of those living with it, their families, and their caregivers. The day commemorates the birth of James Parkinson, who first described the condition in 1817.

Parkinson disease is a progressive neurological condition that impacts movement, cognitive health, sleep, and emotional wellbeing. While it is more commonly diagnosed in older adults, PD can affect people of all ages and backgrounds. Symptoms vary widely, from tremors and rigidity to mental health challenges and cognitive decline. There is currently no cure, but a combination of medicines, surgery, and rehabilitative therapies can help reduce symptoms and improve quality of life.

Pharmalys supports World Parkinson’s Day

At Pharmalys, we stand in solidarity with people living with Parkinson’s and the wider global community working to address the challenges posed by this condition. As an organisation committed to improving access to health data and research across underserved regions, we recognise the need for better diagnosis, earlier intervention, and more equitable access to therapies – especially in low- and middle-income countries where neurological services are often limited.

The World Health Organization’s Intersectoral global action plan on epilepsy and other neurological disorders including PD calls for stronger healthcare systems, better training for non-specialist providers, and greater investment in research and innovation to tackle PD and other neurological conditions.

How we can help

Improving understanding of Parkinson’s is key. We can all contribute by:

· Raising awareness to reduce stigma and misinformation

· Supporting caregivers and families with accessible resources

· Advocating for research and early detection

· Promoting equitable access to treatment and support services

On #WorldParkinsonsDay, Pharmalys reaffirms its commitment to supporting inclusive health initiatives that prioritise neurological care as part of a broader effort to strengthen health systems and improve outcomes for all.

 

Sources:

https://www.who.int/news-room/fact-sheets/detail/parkinson-disease

https://www.parkinsons.org.uk/get-involved/world-parkinsons-day

Movember 2025: Raising Awareness for Men’s Health

Movember 2025: Raising Awareness for Men’s Health

November often signals the start of the festive season in many places, but for men’s health it holds a special significance: Movember. This annual campaign invites men (and those who support them) to pause, reflect and act on several critical health issues that too...

Highlights from the final Pharmalys Voice Meeting of 2025

Highlights from the final Pharmalys Voice Meeting of 2025

On September 25, 2025, Pharmalys held its third and final Pharmalys Voice meeting of the year, bringing together colleagues from across the company in a fun and interactive virtual gathering. The meeting involved presentations from colleagues, engaging discussions,...

Ethiopia Reaches WHO Maturity Level 3

Ethiopia Reaches WHO Maturity Level 3

On 3 October 2025, Dr Mekdes Daba, Health Minister of Ethiopia, announced a major achievement for the country: the formal recognition of the Ethiopian Food and Drug Authority (EFDA) as a Maturity Level 3 (ML3) regulatory system by the World Health Organization (WHO)....

Breast Cancer Awareness 2025: Access and Awareness Saves Lives

Breast Cancer Awareness 2025: Access and Awareness Saves Lives

Breast cancer remains the most common cancer among women worldwide. In the United States, statistics suggest that one in eight women will receive a diagnosis in her lifetime. In 2025 alone, it is estimated that 316,950 women and 2,800 men will be diagnosed with...

A Breakthrough in Malaria Care for the Youngest Patients

A Breakthrough in Malaria Care for the Youngest Patients

It’s a sobering truth: malaria still claims the lives of hundreds of thousands of children every year, with the youngest being most at risk. Until now, doctors treating newborns and very small infants under 5 kg faced a dilemma - no treatment had ever been designed...